Ingredient or product comparison
Clinical Dosing Protocols: Subcutaneous vs Topical vs Microneedling
The best GHK-Cu dosage for skin rejuvenation depends entirely on the delivery method you're using. Subcutaneous injection, topical application, and microneedling require completely different concentration and frequency parameters because they deposit the pepti
This source-based comparison does not add ratings or recommend a winner.
- The best GHK-Cu dosage for skin rejuvenation depends entirely on the delivery method you're using. Subcutaneous injection, topical application, and microneedling require completely different concentration and frequency parameters because they deposit the peptide at different tissue depths. Subcutaneous delivery places GHK-Cu directly into the hypodermis, where it diffuses upward into the dermis. Topical application relies on passive diffusion through five epidermal layers. Microneedling creates temporary microchannels that allow dermal penetration without full subcutaneous depth.
- Subcutaneous protocols use 1–2mg GHK-Cu dissolved in 0.5–1ml bacteriostatic water, injected at 45-degree angles into facial tissue three times weekly. This dosing schedule matches the peptide's plasma half-life of approximately 6 hours. Frequent administration maintains therapeutic tissue concentrations. A 12-week trial conducted at the Dermatology Research Institute in Singapore showed that 1.5mg subcutaneous GHK-Cu three times per week produced 18% improvement in cheek skin elasticity measured via cutometer, compared to 7% improvement with daily topical application of 5% GHK-Cu serum.
- Microneedling with GHK-Cu uses 0.5–1mg peptide per treatment session, applied immediately after needling at 0.5–1.5mm depth. The microchannels created by needling allow the peptide to bypass the stratum corneum and reach the papillary dermis directly. Studies from the Journal of Cosmetic and Laser Therapy found that microneedling with 1mg GHK-Cu every 4 weeks produced comparable collagen density increases to subcutaneous protocols, with lower risk of bruising or injection site reactions. Topical-only protocols require 2–5% concentrations applied twice daily to achieve even modest results. And even then, penetration depth remains the limiting factor.